On Friday, Ghana's parliament passed the Narcotics Control Commission Bill, which will allow the use and cultivation of cannabis for medical and industrial uses -- but only the variety that is better known as hemp.
Lebanon's parliament is set to vote on a law that would legalise the cultivation of cannabis for medical and industrial use in an effort to boost its crippled economy and curb illicit production of the psychoactive plant.
The draft law, which has been endorsed by parliamentary committees and is now headed for a final vote, would only affect cannabis that contains less than one percent of the psychoactive compound tetrahydrocannabidinol, or THC.
While South African officials have said hemp may be approved as an agricultural crop as soon as May this year, some stakeholders remain skeptical of the government’s plans, questioning proposed allowable THC levels and a strategy to rely on imported seeds critics say are ill-suited to the South African environment.
Amid a widespread market selloff due to investor concerns about the COVID-19 outbreak, cannabis companies also have to contend with disruptions involving vaporizer hardware, the vast majority of which is produced in China.
When Thailand’s first official full-time clinic specializing in traditional and alternative cannabis-based medicine opened in January, hopes were high that the greater access to legal medical cannabis could open doors for the country’s tourism sector to reap the economic benefits of marijuana-inspired travel into Southeast Asia.
The U.S. hemp market continues to heat up for a variety of reasons, mainly because the general populace is finally starting to understand the difference between cannabis as marijuana and cannabis as hemp (and the benefits of CBD and other cannabinoids derived from cannabis). In this post I’ll discuss why China’s pain can be U.S. hemp producers’ gain.
The UK government has now approved changes to import restrictions to ensure that people with prescriptions for cannabis-based products for medical use do not have their treatment delayed or interrupted.